Dr. Deborah Sumari is a molecular biologist and Research Scientist in the Interventions and Clinical Trials Department. Dr. Sumari joined the Institute in 2004 as a MSc. Candidate, conducting her research on drug resistant genotypes of Plasmodium falciparum parasites for first line monotherapy malaria treatment (SP) in comparison to new antimalarial drugs (combination therapy-ACT) expected to be deployed countrywide. Her results were amongst those that contributed to the withdrawal of SP as first line treatment of malaria in Tanzania. She attained a Master’s degree in Molecular Biology from the University of Dar es Salaam in 2007. Dr. Sumari obtained her PhD in Life Sciences and Bioengineering from The Nelson Mandela African Institution of Science and Technology in 2016. Her research project was the first study testing and using magnetic cytosmear technique for diagnosing malaria patient in the field. She further plans to apply the magnetic devices in the identification and separation of free labelled-cancer cells. Additionally, Dr Sumari’s has established key collaborations with international institutes, including Cleveland Clinic Foundation and CASE Western Reserve University, and CDC Atlanta – Division of Parasitic Diseases and Malaria on malaria surveillance studies. Her other interests include evaluation of non-communicable diseases in children, establishment of a point-of-care device that can frequently assess the effect of intervention and control measures in the country. Dr Sumari has significant experience in her field and strong collaborative skills that strengthen research activities in the Institute.